The stock price for Bristol-Myers Squibb is up by roughly 15% in the last few years (since Jan 2017), driven by the company's increased market share in the anticoagulants market. In comparison, Pfizer, one of the largest U.S. pharmaceutical companies in terms of market cap, has seen its stock grow..
The stock price for Bristol-Myers Squibb is up by roughly 15% in the last few years (since Jan 2017), driven by the company's increased market share in the anticoagulants market. In comparison, Pfizer, one of the largest U.S. pharmaceutical companies in terms of market cap, has seen its stock grow..
Share this Article
Recommended